Company Overview
| Stock Name | Meihao Group |
|---|---|
| Stock Code | 01947 |
| Company Full Name | To be extracted |
| Industry | Healthcare |
| Principal Activities | 主要向個人提供綜合牙科服務,涵蓋口腔綜合治療科、口腔修復科、種植牙科及牙齒正畸科四個牙科領域,於溫州經營五家民營牙科醫院。 |
| Listing Date | 2022-12-14 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國浙江省溫州市鹿城區府前街197號 |
| Business Address (Hong Kong) | 香港灣仔皇后大道東183號合和中心46樓 |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | www.meihaomedical.com |
| Share Registrar | 香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No |
Offering Information
| Offering Mechanism | Mechanism A |
|---|---|
| Offer Price | HK$ 0.84 / shares |
| Offer Price Range | Final offer price only, no range |
| Lot Size | 5,000 shares |
| Entry Threshold | HK$ 4,200 |
| Par Value | To be extracted |
| Offer Period | 2022-11-30 to 2022-12-06 |
| Global Offering Shares | 150,000,000 shares |
| HK Public Offer Shares (Initial) | 15,000,000 shares (10.0%) |
| Public Offer Lots (Initial) | 3,000lots (Pool A1,500lots,Pool B1,500lots) |
| International Placing Shares (Initial) | 135,000,000 shares (90.0%) |
| Offer Ratio | ~10.0% |
| Total Shares Post-IPO | 600,000,000 shares |
| Greenshoe (Over-allotment Option) | Yes |
| Stabilizing Manager (Greenshoe) | To be extracted |
| Cornerstone Share | No cornerstone investors |
| Clawback Tiers | To be extracted |
| Reallocation Option | Yes |
| Total Global Offering Size | HK$ 126,000,000 |
Subscription Tiers
Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.
Pool A
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 1 lots | 5,000 | HK$ 4,200 |
| 2 lots | 10,000 | HK$ 8,400 |
| 3 lots | 15,000 | HK$ 12,600 |
| 4 lots | 20,000 | HK$ 16,800 |
| 5 lots | 25,000 | HK$ 21,000 |
| 6 lots | 30,000 | HK$ 25,200 |
| 7 lots | 35,000 | HK$ 29,400 |
| 8 lots | 40,000 | HK$ 33,600 |
| 9 lots | 45,000 | HK$ 37,800 |
| 10 lots | 50,000 | HK$ 42,000 |
| 12 lots | 60,000 | HK$ 50,400 |
| 14 lots | 70,000 | HK$ 58,800 |
| 16 lots | 80,000 | HK$ 67,200 |
| 18 lots | 90,000 | HK$ 75,600 |
| 20 lots | 100,000 | HK$ 84,000 |
| 30 lots | 150,000 | HK$ 126,000 |
| 40 lots | 200,000 | HK$ 168,000 |
| 50 lots | 250,000 | HK$ 210,000 |
| 60 lots | 300,000 | HK$ 252,000 |
| 70 lots | 350,000 | HK$ 294,000 |
| 80 lots | 400,000 | HK$ 336,000 |
| 90 lots | 450,000 | HK$ 378,000 |
| 100 lots | 500,000 | HK$ 420,000 |
| 120 lots | 600,000 | HK$ 504,000 |
| 140 lots | 700,000 | HK$ 588,000 |
| 160 lots | 800,000 | HK$ 672,000 |
| 180 lots | 900,000 | HK$ 756,000 |
| 200 lots | 1,000,000 | HK$ 840,000 |
| 300 lots | 1,500,000 | HK$ 1,260,000 |
| 400 lots | 2,000,000 | HK$ 1,680,000 |
| 500 lots | 2,500,000 | HK$ 2,100,000 |
| 600 lots | 3,000,000 | HK$ 2,520,000 |
| 800 lots | 4,000,000 | HK$ 3,360,000 |
| 1,000 lots | 5,000,000 | HK$ 4,200,000 |
| 1,100 lots | 5,500,000 | HK$ 4,620,000 |
Pool B
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 1,200 lots | 6,000,000 | HK$ 5,040,000 |
| 1,400 lots | 7,000,000 | HK$ 5,880,000 |
| 1,500 lots | 7,500,000 | HK$ 6,300,000 |
Stock Connect Inclusion Analysis
| 26Q4 Regular Review | |
| Inclusion Pathway | Regular Path |
|---|---|
| Avg Daily HK Mkt Cap | HK$ 287.8M |
| Est. Threshold | HK$ 9.71B |
| Analysis Result | HK market cap below threshold, need +3275% |
Valuation & Financials
| Market Cap (at Offer Price) | HK$ 504,000,000 |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | 盈利約人民幣32.2百萬元 |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
Financial Data
Unit:
'000
RMB
Income Statement
| Item | 2019 | 2020 | 2021 |
|---|---|---|---|
| Revenue | 83,159 | 84,556 | 105,315 |
| Cost of sales | -37,888 | -33,939 | -38,385 |
| Gross profit | 45,271 | 50,617 | 66,930 |
| Other income and gains, net | 368 | 907 | 1,662 |
| Selling and distribution expenses | -4,894 | -3,918 | -5,119 |
| Administrative expenses | -16,451 | -21,327 | -17,485 |
| Operating profit | 24,076 | 26,026 | 46,138 |
| Net finance costs | -994 | -1,834 | -2,471 |
| Profit before tax | 23,082 | 24,192 | 43,667 |
| Income tax expense | -7,619 | -9,212 | -11,490 |
| Profit for the year | 15,463 | 14,980 | 32,177 |
| Profit attributable to owners | 15,429 | 14,903 | 32,069 |
Balance Sheet
| Item | 2019 | 2020 | 2021 | 2022-05 |
|---|---|---|---|---|
| Cash and cash equivalents | 42,162 | 50,974 | 41,283 | |
| Trade and bills receivables | 863 | 710 | 600 | |
| Inventories | 1,773 | 1,583 | 2,363 | |
| Total current assets | 58,481 | 63,423 | 55,433 | |
| Total assets | 99,111 | 98,365 | 133,866 | |
| Total current liabilities | 64,122 | 67,095 | 47,757 | |
| Total liabilities | 79,241 | 79,999 | 83,323 | |
| Total equity | 19,870 | 18,366 | 50,543 | |
| Equity attributable to owners | 19,790 | 18,209 | 50,278 | |
| Interest-bearing borrowings | 0 | 25,856 | 0 | 0 |
Cash Flow Statement
| Item | 2019 | 2020 | 2021 | 2022-05 |
|---|---|---|---|---|
| Net cash from operating activities | 19,378 | 27,454 | 46,560 | |
| Net cash from investing activities | 1,651 | -690 | -18,408 | |
| Net cash from financing activities | 17,934 | -17,952 | -37,843 | |
| Net increase in cash | 38,963 | 8,812 | -9,691 | |
| Depreciation of PP&E | 3,512 | 3,887 | 4,491 | 2,838 |
| Depreciation of right-of-use assets | 3,535 | 4,254 | 6,387 | 2,756 |
| Amortisation of intangible assets | 69 | 75 | 98 | 94 |
| Purchase of PP&E | -2,079 | -3,390 | -17,958 | -2,010 |
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
| First Day Close | HK$ 0.72 |
|---|---|
| First Day Open | HK$ 0.76 |
| First Day Change | -40.48% |
| First Day Volume | 67305000.0 |
| First Day Turnover | 51641000.0 |
| Use of Proceeds | 1、約28.6%或21.4百萬港元將用于潛在策略性收購中國兩家牙科醫院;
2、約27.0%或20.2百萬港元將用于撥付溫州口腔發展的資本支出及初始經營成本;
3、約14.1%或10.6百萬港元將用于撥付在溫州建立鹿城兒童醫院的資本支出及初始經營成本;
4、約10.0%或7.5百萬港元將用于營運資金及其他一般公司用途;
5、約8.6%或6.4百萬港元將用于撥付在溫州以外地區以新商標名成立連鎖牙科診所的資本支出及初始經營成本;
6、約5.4%或4.0百萬港元將用于設立牙科培訓中心,以匯集牙醫人才及提升牙科服務質量;
7、約3.3%或2.5百萬港元將用于購置新的牙科設備和耗材,以提升我們提供的牙科服務質量;
8、約3.0%或2.3百萬港元將用于翻新溫州醫院以擴充兒童牙科部。 |
Underwriting Syndicate
Joint Sponsors (2)
Joint Bookrunners (9)
AUSTRAX SECURITIES LIMITED CE BHV052
WE Securities Limited CE BMQ962
SINOLINK SECURITIES (HONG KONG) COMPANY LIMITED CE AAI195
国泰君安证券(香港)有限公司 CE ABY236
建银国际金融有限公司 CE AJO225
民银证券有限公司 CE APU820
老虎证券(香港)环球有限公司 CE BMU940
SDHG International Securities Limited CE ADY241
HGNH International Securities Co., Limited CE BBT518
Joint Lead Managers (9)
AUSTRAX SECURITIES LIMITED CE BHV052
WE Securities Limited CE BMQ962
SINOLINK SECURITIES (HONG KONG) COMPANY LIMITED CE AAI195
国泰君安证券(香港)有限公司 CE ABY236
建银国际金融有限公司 CE AJO225
民银证券有限公司 CE APU820
老虎证券(香港)环球有限公司 CE BMU940
SDHG International Securities Limited CE ADY241
HGNH International Securities Co., Limited CE BBT518
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | 王曉敏 | — |
| Company Secretary | 李忠成 | — |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 王曉敏先生及鄭蠻女士(配偶)通過JTC BVI、Ricon BVI及Meihao BVI合共持有緊隨全球發售及資本化發行完成後本公司約71.25%股權。 |
|---|




